α-Synuclein oligomers distinctively permeabilize complex model membranes

FEBS Journal

Volumn 281, Issue 12, 2014, Pages 2838-2850

  Stefanovic, Anja N D ^a   Stöckl, Martin T ^a,b   Claessens, Mireille M A E ^a   Subramaniam, Vinod ^a,c  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c FOM INSTITUTE AMOLF   (Netherlands)

Author keywords

cardiolipin; model membranes; oligomers; permeabilization; synuclein

Indexed keywords

ALPHA SYNUCLEIN; OLIGOMER;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION;

CARDIOLIPIN; MODEL MEMBRANES; OLIGOMERS; PERMEABILIZATION; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; BIOPOLYMERS; CIRCULAR DICHROISM; COLORING AGENTS; HUMANS; KINETICS; LIPID BILAYERS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PERMEABILITY;

EID: 84902668958     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12824     Document Type: Article

References (68)

1. Cookson MR, (2009) alpha-Synuclein and neuronal cell death. Mol Neurodegener 4, 9.
2. Eliezer D, Kutluay E, Bussell R Jr, &, Browne G, (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307, 1061-1073.
3. Uversky VN, Li J, &, Fink AL, (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276, 10737-10744.
4. Lorenzen N, Nielsen SB, Buell AK, Kaspersen JD, Arosio P, Vad BS, Paslawski W, Christiansen G, Valnickova-Hansen Z, Andreasen M, et al,. (2014) The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J Am Chem Soc 136, 3859-3868.
5. Roche J, Ying JF, Maltsev AS, &, Bax A, (2013) Impact of hydrostatic pressure on an intrinsically disordered protein: a high-pressure NMR study of alpha-synuclein. ChemBioChem 14, 1754-1761.
6. Zanzoni A, Marchese D, Agostini F, Bolognesi B, Cirillo D, Botta-Orfila M, Livi CM, Rodriguez-Mulero S, &, Tartaglia GG, (2013) Principles of self-organization in biological pathways: a hypothesis on the autogenous association of alpha-synuclein. Nucleic Acids Res 41, 9987-9998.
7. Breydo L, Wu JW, &, Uversky VN, (2012) Alpha-synuclein misfolding and Parkinson's disease. Biochim Biophys Acta 1822, 261-285.
8. Uversky VN, (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103, 17-37.
9. Auluck PK, Caraveo G, &, Lindquist S, (2010) alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol 26, 211-233.
10. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, &, Glabe CG, (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
11. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, &, Glabe CG, (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279, 46363-46366.
12. Jao CC, Hegde BG, Chen J, Haworth IS, &, Langen R, (2008) Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105, 19666-19671.
13. Davidson WS, Jonas A, Clayton DF, &, George JM, (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273, 9443-9449.
14. Rhoades E, Ramlall TF, Webb WW, &, Eliezer D, (2006) Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. Biophys J 90, 4692-4700.
15. Middleton ER, &, Rhoades E, (2010) Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys J 99, 2279-2288.
16. Shvadchak VV, Yushchenko DA, Pievo R, &, Jovin TM, (2011) The mode of alpha-synuclein binding to membranes depends on lipid composition and lipid to protein ratio. FEBS Lett 585, 3513-3519.
17. Kjaer L, Giehm L, Heimburg T, &, Otzen D, (2009) The influence of vesicle size and composition on alpha-synuclein structure and stability. Biophys J 96, 2857-2870.
18. Pandey AP, Haque F, Rochet JC, &, Hovis JS, (2009) Clustering of alpha-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration. Biophys J 96, 540-551.
19. Stockl M, Fischer P, Wanker E, &, Herrmann A, (2008) Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J Mol Biol 375, 1394-1404.
20. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, &, Kostka M, (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27, 9220-9232.
21. Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, Galatis D, Sharples RA, Curtain CC, Ali FE, Cherny RA, et al,. (2005) Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J 19, 1377-1379.
22. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, &, Lansbury PT Jr, (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322, 1089-1102.
23. van Rooijen BD, Claessens MM, &, Subramaniam V, (2009) Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim Biophys Acta 1788, 1271-1278.
24. van Rooijen BD, Claessens MM, &, Subramaniam V, (2010) Membrane permeabilization by oligomeric a-synuclein: in search of the mechanism. PLoS One 13, e14292.
25. Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, Kessler JC, &, Lansbury PT Jr, (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819.
26. Meratan AA, Ghasemi A, &, Nemat-Gorgani M, (2011) Membrane integrity and amyloid cytotoxicity: a model study involving mitochondria and lysozyme fibrillation products. J Mol Biol 409, 826-838.
27. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, et al,. (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 286, 20710-20726.
28. Yong-Kee CJ, Sidorova E, Hanif A, Perera G, &, Nash JE, (2012) Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease. Neurotox Res 21, 185-194.
29. Ardail D, Privat JP, Egret-Charlier M, Levrat C, Lerme F, &, Louisot P, (1990) Mitochondrial contact sites. Lipid composition and dynamics. J Biol Chem 265, 18797-18802.
30. Ramakrishnan M, Jensen PH, &, Marsh D, (2003) Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry 42, 12919-12926.
31. Zigoneanu IG, Yang YJ, Krois AS, Haque E, &, Pielak GJ, (2012) Interaction of alpha-synuclein with vesicles that mimic mitochondrial membranes. Biochim Biophys Acta 1818, 512-519.
32. Liu G, Zhang C, Yin J, Li X, Cheng F, Li Y, Yang H, Ueda K, Chan P, &, Yu S, (2009) alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 454, 187-192.
33. Li WW, Yang R, Guo JC, Ren HM, Zha XL, Cheng JS, &, Cai DF, (2007) Localization of a-synuclein to mitochondria within midbrain of mice. NeuroReport 18, 1543-1546.
34. Parihar MS, Parihar A, Fujita M, Hashimoto M, &, Ghafourifar P, (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci 65, 1272-1284.
35. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, &, Anandatheerthavarada HK, (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283, 9089-9100.
36. Devi L, &, Anandatheerthavarada HK, (2010) Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim Biophys Acta 1802, 11-19.
37. Guardia-Laguarta C, Area-Gomez E, Rub C, Liu Y, Magrane J, Becker D, Voos W, Schon EA, &, Przedborski S, (2014) alpha-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 34, 249-259.
38. Fauvet B, Fares MB, Samuel F, Dikiy I, Tandon A, Eliezer D, &, Lashuel HA, (2012) Characterization of semisynthetic and naturally Nalpha-acetylated alpha-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of alpha-synuclein. J Biol Chem 287, 28243-28262.
39. Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, Caldwell KA, Caldwell GA, Rochet JC, McCaffery JM, et al,. (2008) The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 105, 145-150.
40. Fiske M, White M, Valtierra S, Herrera S, Solvang K, Konnikova A, &, Debburman S, (2011) Familial Parkinson's disease mutant E46K alpha-synuclein localizes to membranous structures, forms aggregates, and induces toxicity in yeast models. ISRN Neurol 2011, 521847.
41. Pacheco C, Aguayo LG, &, Opazo C, (2012) An extracellular mechanism that can explain the neurotoxic effects of alpha-synuclein aggregates in the brain. Front Physiol 3, 297.
42. Jo E, McLaurin J, Yip CM, St George-Hyslop P, &, Fraser PE, (2000) alpha-Synuclein membrane interactions and lipid specificity. J Biol Chem 275, 34328-34334.
43. van Rooijen BD, Claessens MM, &, Subramaniam V, (2008) Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing. FEBS Lett 582, 3788-3792.
44. Zhu M, Li J, &, Fink AL, (2003) The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem 278, 40186-40197.
45. Wang GF, Li C, &, Pielak GJ, (2010) 19F NMR studies of alpha-synuclein-membrane interactions. Protein Sci 19, 1686-1691.
46. Zigoneanu IG, Yang YJ, Krois AS, Haque E, &, Pielak GJ, (2012) Interaction of alpha-synuclein with vesicles that mimic mitochondrial membranes. Biochim Biophys Acta 1818, 512-519.
47. Pfefferkorn CM, &, Lee JC, (2010) Tryptophan probes at the alpha-synuclein and membrane interface. J Phys Chem B 114, 4615-4622.
48. Shvadchak VV, Falomir-Lockhart LJ, Yushchenko DA, &, Jovin TM, (2011) Specificity and kinetics of alpha-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. J Biol Chem 286, 13023-13032.
49. Schwiering M, &, Hellmann N, (2012) Validation of liposomal lipid composition by thin-layer chromatography. J Liposome Res 22, 279-284.
50. Chandra S, Chen X, Rizo J, Jahn R, &, Sudhof TC, (2003) A broken alpha -helix in folded alpha -Synuclein. J Biol Chem 278, 15313-15318.
51. Bartels T, Ahlstrom LS, Leftin A, Kamp F, Haass C, Brown MF, &, Beyer K, (2010) The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding. Biophys J 99, 2116-2124.
52. Volles M, &, Lansbury P, (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595-4602.
53. Maherani B, Arab-Tehrany E, Kheirolomoom A, Geny D, &, Linder M, (2013) Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Biochimie 95, 2018-2033.
54. Shimanouchi T, Ishii H, Yoshimoto N, Umakoshi H, &, Kuboi R, (2009) Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization. Colloids Surf B Biointerfaces 73, 156-160.
55. Ouberai MM, Wang J, Swann MJ, Galvagnion C, Guilliams T, Dobson CM, &, Welland ME, (2013) alpha-Synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling. J Biol Chem 288, 20883-20895.
56. Leftin A, Job C, Beyer K, &, Brown MF, (2013) Solid-state 13C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-synuclein. J Mol Biol 425, 2973-2987.
57. Fantini J, &, Yahi N, (2013) The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. Adv Exp Med Biol 991, 15-26.
58. Fantini J, Carlus D, &, Yahi N, (2011) The fusogenic tilted peptide (67-78) of alpha-synuclein is a cholesterol binding domain. Biochim Biophys Acta 1808, 2343-2351.
59. Brender JR, Lee EL, Hartman K, Wong PT, Ramamoorthy A, Steel DG, &, Gafni A, (2011) Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys J 100, 685-692.
60. Zijlstra N, Blum C, Segers-Nolten IM, Claessens MM, &, Subramaniam V, (2012) Molecular composition of sub-stoichiometrically labeled alpha-synuclein oligomers determined by single-molecule photobleaching. Angew Chem Int Ed Engl 51, 8821-8824.
61. Camilleri A, Zarb C, Caruana M, Ostermeier U, Ghio S, Hogen T, Schmidt F, Giese A, &, Vassallo N, (2013) Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols. Biochim Biophys Acta 1828, 2532-2543.
62. van Raaij ME, Segers-Nolten IMJ, &, Subramaniam V, (2006) Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from α-synuclein mutants. Biophys J 91, L96-L98.
63. Pace CN, Vajdos F, Fee L, Grimsley G, &, Gray T, (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4, 2411-2423.
64. van Meer G, Voelker DR, &, Feigenson GW, (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9, 112-124.
65. Angelova MI, &, Dimitrov DS, (1986) Liposome electroformation. Faraday Disc Chem Soc 81, 303-311.
66. Barrow CJ, Yasuda A, Kenny PT, &, Zagorski MG, (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. J Mol Biol 225, 1075-1093.
67. Chen YH, Yang JT, &, Chau KH, (1974) Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 13, 3350-3359.
68. Scholtz JM, Qian H, York EJ, Stewart JM, &, Baldwin RL, (1991) Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers 31, 1463-1470.